Loading companies…
United States · Biotech
Develops oligonucleotide therapeutics targeting chronic hepatitis B
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $120M | CDH Investments — Role not disclosedHanKang Capital — Role not disclosedInnoPinnacle Fund — Role not disclosedQiming Venture Partners — Role not disclosedRA Capital Management — Role not disclosedSherpa Capital — Role not disclosedYuanBio Venture Capital — Role not disclosed |